Trials / Completed
CompletedNCT00190996
Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence
The Safety and Effectiveness of Duloxetine Compared With Placebo and Its Long-Term Safety and Efficacy in the Treatment of Predominant Stress Urinary Incontinence
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2,765 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purposes of this study are to determine whether duloxetine can help subjects with stress urinary incontinence and to see whether the effects of duloxetine can be maintained.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine Hydrochloride | |
| DRUG | placebo |
Timeline
- Start date
- 2003-01-01
- Completion
- 2006-06-01
- First posted
- 2005-09-19
- Last updated
- 2007-01-26
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00190996. Inclusion in this directory is not an endorsement.